Japan
Tuberculosis profile
Population  2013 127 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 2.1 (2.1–2.2) 1.7 (1.6–1.7)
Mortality (HIV+TB only) 0.01 (<0.01–0.016) 0.01 (0–0.01)
Prevalence  (includes HIV+TB) 29 (11–55) 23 (9–43)
Incidence  (includes HIV+TB) 23 (22–26) 18 (17–20)
Incidence (HIV+TB only) 0.083 (0.054–0.11) 0.07 (0.04–0.09)
Case detection, all forms (%) 88 (79–93)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.7 (0.42–1.1) 9.8 (7.1–13)
MDR-TB cases among notified pulmonary
TB cases
110 (63–160) 100 (72–130)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 12 758   831
Pulmonary, clinically diagnosed 2 201   182
Extrapulmonary 4 274   249
       
Total new and relapse 20 495    
Previously treated, excluding relapses      
Total cases notified 20 495    
Among 20 495 new and relapse cases:
66 (<1%) cases aged under 15 years; male:female ratio: 1.6
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 7 266 (57%) 435 (34%) 7 701
Laboratory-confirmed RR-/MDR-TB cases     64
Patients started on MDR-TB treatment      
TB/HIV 2013 Number (%)
TB patients with known HIV status 1 940 (9)
HIV-positive TB patients 50 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New cases registered in 2012 54
Previously treated cases registered in 2012 49
HIV-positive TB cases, all types, registered in 2012 30
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 48
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-29 Data: www.who.int/tb/data